ORTHOCELL LIMITED ORDINARY (OCC) Short Interest
ORTHOCELL LIMITED ORDINARY (ASX:OCC) had 0.42% of shares reported as short positions as of 26 June 2026, representing 1,137,952 shares. ORTHOCELL LIMITED ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
OCC
Orthocell
Orthocell is a leader in the regenerative medicine sector, focusing on innovative treatments for chronic degenerative diseases and injuries. The company specializes in developing collagen medical devices and cell therapies that leverage the body's natural repair mechanisms. Orthocell's products are designed to enhance surgical repair and promote tissue regeneration, positioning it as a pioneer in ...